Ethanol-induced behavioral sensitization is associated with dopamine receptor changes in the mouse olfactory tubercle

Ethanol-induced behavioral sensitization is associated with dopamine receptor changes in the mouse olfactory tubercle

Physiology & Behavior 96 (2009) 12–17 Contents lists available at ScienceDirect Physiology & Behavior j o u r n a l h o m e p a g e : w w w. e l s e...

584KB Sizes 0 Downloads 81 Views

Physiology & Behavior 96 (2009) 12–17

Contents lists available at ScienceDirect

Physiology & Behavior j o u r n a l h o m e p a g e : w w w. e l s ev i e r. c o m / l o c a t e / p h b

Ethanol-induced behavioral sensitization is associated with dopamine receptor changes in the mouse olfactory tubercle☆ Nilza Pereira de Araujo a,1, Daniela Fukue Fukushiro a,1, Christian Grassl a, Débora C. Hipólide b, Maria Lúcia O. Souza-Formigoni b, Sergio Tufik b, Roberto Frussa-Filho a,⁎ a b

Department of Pharmacology, Universidade Federal de São Paulo, R. Botucatu, 862, Ed. Leal Prado, 1° andar, 04023062, São Paulo-SP, Brazil Department of Psychobiology, Universidade Federal de São Paulo, R. Napoleão de Barros, 925, Vl. Clementino, 04024002, São Paulo-SP, Brazil

a r t i c l e

i n f o

Article history: Received 31 March 2008 Received in revised form 29 July 2008 Accepted 30 July 2008 Keywords: Behavioral sensitization D2 binding Ethanol Olfactory tubercle

a b s t r a c t Accumulating evidence points to the mesolimbic and the nigrostriatal dopamine systems as critical to behavioral sensitization induced by several drugs of abuse. In the present study, we analyzed D1 and D2 binding to brain regions related to these dopaminergic systems during the expression of ethanol-induced behavioral sensitization. The first experiment was performed to demonstrate the effectiveness of the ethanol treatment schedule and challenge used to induce the expression of the behavioral sensitization phenomenon. The second experiment was conducted to study D1 and D2 alterations in several brain regions during the expression of this phenomenon. Mice were ip treated with ethanol or saline for 21 consecutive days and 24 h after the last injection they received an ethanol or a saline challenge injection. Five minutes later, the animals were observed in an open-field for locomotion quantification or were sacrificed and their brains were submitted to autoradiographic binding analyses. No differences among the groups were found for D1 binding levels in all the brain regions analyzed. However, ethanol-sensitized mice showed reduced levels of D2 binding in the olfactory tubercle when compared to the other groups. Our data suggest that D2 receptor changes in the olfactory tubercle seem to play an important role in the expression of ethanol-induced behavioral sensitization. © 2008 Elsevier Inc. All rights reserved.

1. Introduction Although many effects elicited by repeated drug treatments exhibit tolerance after some time, the psychomotor and positive reinforcing effects of a number of drugs of abuse often become greater with repeated administration [1–4]. The latter phenomenon is named behavioral sensitization and is usually behaviorally expressed by an increase in drug-induced hyperactivity or stereotypy of rodents [4–7]. Undoubtedly, psychostimulants have been the focus of most of research in the field of the behavioral sensitization phenomenon. Consequently, very little importance has been given to sensitization to the locomotor stimulant effect of ethanol. One possible reason for the lack of attention paid to this drug could be its complex effects on various neurotransmission systems, such as catecholaminergic, opioid, glutamatergic, serotonergic, GABAergic and cholinergic systems. In this respect, the effects of ethanol on dopaminergic neurotransmission seem to be of great relevance to its locomotor stimulant effect as well as to its

☆ Financial support: CNPq, FAPESP, CAPES, AFIP, FADA. ⁎ Corresponding author. Departamento de Farmacologia—UNIFESP, Rua Botucatu, 862-Ed. Leal Prado 1° andar-04023062-São Paulo, SP-Brazil. Tel.: +55 11 5549 4122x219; fax: +55 11 5549 4122x222. E-mail address: [email protected] (R. Frussa-Filho). 1 The first two authors had the same contribution to this study. 0031-9384/$ – see front matter © 2008 Elsevier Inc. All rights reserved. doi:10.1016/j.physbeh.2008.07.029

reinforcing properties [8]. Usually, high doses of ethanol produce sedation and hypnosis, which are subjected to tolerance after repeated treatment. Conversely, low doses produce behavioral stimulation, which is sensitized after repeated injections [9,10]. Behavioral sensitization has been suggested to be a useful animal model to study drug craving in humans [11], since the brain circuitries involved in psychomotor stimulation and in reward seem to be closely related or even identical [12]. Within this context, ample evidence suggests that the mesolimbic and the nigrostriatal dopamine systems mediate most of the neuroadaptations related to behavioral sensitization induced by distinct drugs of abuse [4,13–16]. Furthermore, alterations in brain dopamine receptors, particularly D1 and D2, in the mesolimbic and the nigrostriatal dopamine systems, have been generally associated with chronic treatment with drugs of abuse in humans [17–19] and in animals [20–22]. Specifically concerning ethanol, there are some accounts in the literature showing changes in D1 and/or D2 binding to different brain regions related to reward in ethanol-sensitized animals [23–25]. Notwithstanding, as far as we know, all of them examined dopamine receptor binding when animals were withdrawn from ethanol treatment for different periods of time, and not at the time point of the behavioral expression of sensitization. Importantly, no significant behavioral alteration has been reported in mice withdrawn from repeated treatment with “stimulant doses” of ethanol [26]. Therefore, receptor binding assays

N.P. de Araujo et al. / Physiology & Behavior 96 (2009) 12–17

performed at the moment of the expression of behavioral sensitization (i.e., right after the ethanol challenge injection in ethanol pre-treated animals, when sensitization is behaviorally expressed) would be of special interest for better elucidation of mechanisms underlying the development and the expression of ethanol-induced behavioral sensitization. In the present study, we have examined the pattern of D1 and D2 binding to brain regions belonging to the mesolimbic (ventral tegmental area, nucleus accumbens and olfactory tubercle) and the nigrostriatal (substantia nigra and caudate-putamen) dopamine systems during the expression of behavioral sensitization induced by ethanol in mice. 2. Materials and methods 2.1. Animals Three-month-old Swiss EPM-M1 female mice were used. The animals were housed in groups of 15 in polypropylene cages (41 × 34 × 16.5 cm) containing white pine bedding, with free access to food and water, in a room with controlled temperature (22–23 °C) and under a 12/12 h light/dark cycle (lights on at 07:00 h). Female mice were used mainly because it has been demonstrated that behavioral sensitization is higher in female animals [4]. Animals used in this study were maintained in accordance with the guidelines of the National Institute of Health Guide for Care and Use of Laboratory Animals (NIH Publications N 85-23, revised 1996). In addition, all efforts were made to minimize the number of animals used and their suffering. A total of 60 mice were used in the present study (30 for experiment 1 and 30 for experiment 2). 2.2. Drugs Ethanol (MERCK®) was administered in a 12% w/v solution diluted in saline. Saline was used as control solution. The solutions were given intraperitoneally in the volume of 10 ml/kg body weight. 2.3. Experimental procedure 2.3.1. Experiment 1: Behavioral sensitization induced by ethanol repeated administration in mice Thirty female Swiss mice were randomly allocated to 3 groups of 10 animals each: SAL–SAL, SAL–EtOH and EtOH–EtOH. On days 1–21 animals from the SAL–SAL and SAL–EtOH groups received an intraperitoneal (i.p.) injection of saline (SAL) and animals from the EtOH–EtOH group received an i.p. injection of 1.8 g/kg ethanol (EtOH) once a day. On day 22, the SAL–SAL group received an i.p. challenge injection of SAL whereas the SAL–EtOH and EtOH–EtOH groups received an i.p. challenge injection of 1.8 g/kg EtOH and, 5 min later, they were placed into the open-field for locomotor activity quantification in a 5-min session. During the 5-min period between the challenge injection and behavioral testing, mice were individually placed in separate boxes. During ethanol or saline repeated treatment animals were maintained in optimum housing conditions (see references [27,28]) for the development of ethanol-induced behavioral sensitization. Due to the short-lasting stimulant effect of ethanol on mice’s locomotor activity, the quantification of this behavioral parameter for 5 min has been shown to be effective and sufficient to demonstrate ethanolinduced hyperlocomotion and its sensitization under our laboratory conditions [27–29]. Similarly, the ethanol dose and the withdrawal period between repeated treatment and challenge session (24 h) were chosen on the basis of previous studies of our research group, which succeeded to demonstrate behavioral sensitization to ethanol in mice [26,30].

13

Behavioral test Five minutes after the ethanol challenge injection, the animals were individually placed in the center of the open-field arena for direct quantification of locomotion frequency for 5 min. The openfield apparatus used in the present study was a circular wooden box (40 cm in diameter and 50 cm high) with an open top and floor divided into 19 squares. Hand-operated counters were used to score locomotion frequency (number of floor units entered) during the 5min session. The observer was always unaware of the experimental design. The animals were used only once. The behavioral test took place between 08:00 a.m. and 11:00 a.m. and a 60-min habituation of the animals to the testing room was allowed before its beginning. Locomotion frequency quantified in the open-field apparatus has been demonstrated to be a very effective method to evaluate behavioral sensitization induced by ethanol [26,27] or other drugs of abuse [6,26,31,32]. In addition, open-field locomotion of rodents has been extensively proven to be a very sensitive behavioral parameter to evaluate the effects of drugs acting on dopamine systems [33–36]. 2.3.2. Experiment 2: D1 and D2 binding analyses during the expression of ethanol-induced behavioral sensitization in mice Other 30 female Swiss mice were used in this experiment, which followed the same protocol of the experiment 1, except that 5 min after the challenge injection, instead of being submitted to the behavioral test, mice were sacrificed by decapitation and had their brains removed for autoradiographic D1 or D2 binding analyses. Autoradiographic binding assays Five minutes after the ethanol challenge injection, mice were sacrificed by decapitation and their brains were immediately removed, frozen over dry ice and stored at −80 °C until cryostat sectioning. Serial 20 μm coronal sections were cut on Leica cryostat at −20 °C, collected onto glass slides and stored at −80 °C until the day of the assays. D1 binding was analyzed with [3H] SCH 23390, as previously described by Quadros et al. [37]. D2 binding analyses were conducted using [3H] Raclopride, as described by SouzaFormigoni et al. [24] earlier. Briefly, slices were brought to room temperature and then pre-incubated in 50 mM Tris–HCl (120 mM NaCl·4 mM MgCl2·1 mM EDTA·1.5 mM CaCl2·2H2O) buffer (pH = 7.4) for 30 (D1) or 15 (D2) minutes. Sections were then incubated in buffer containing 2 nM [3H] SCH 23390 (86.0 Ci/mmol, Perkin Elmer Life Science, Boston, USA) for 90 min at 37 °C (D1) or in buffer containing 2 nM [3H] Raclopride (76.0 Ci/mmol, Perkin Elmer Life Science, Boston, USA) for 2 h at room temperature (D2). Additional sets of slices were incubated in the presence of either 2 μM butaclamol (D1) or 10 μM sulpiride (D2), for determination of nonspecific binding. Sections were then washed once (D1) or twice (D2) in buffer for 5 min, followed by one quick dip rinse of ice-cold distilled water before drying. Slices were exposed to Kodak Biomax MR-1 in tungsten cassettes together with calibrated standards for 4 weeks. All groups were represented in each film. Films were developed and densitometric analyses performed using the MCID system (Imaging Research, St. Catherine's, Ontario, Canada). At least five sections were measured to obtain values for each mouse for each region. Anatomical regions were defined according to the mouse brain atlas of Franklin and Paxinos [38]. 2.4. Statistical analyses For the behavioral test, one-way ANOVA followed by Duncan’s test was used. For autoradiographic binding assays, parametric data were treated using one-way ANOVA followed by Tukey-HSD test and nonparametric data were treated with one-way ANOVA followed by Dunnett-T3 test. A p value less than 0.05 was considered as a statistically significant difference for all comparisons made. Still concerning the

14

N.P. de Araujo et al. / Physiology & Behavior 96 (2009) 12–17 Table 1 [3H] SCH-23390 binding to D1 receptors after a saline or an ethanol challenge injection in saline- or ethanol-treated mice

Caudate-putamen Anterior Posterior Dorsomedial Dorsolateral Ventrolateral Nucleus accumbens Core Shell Olfactory tubercle Substantia Nigra Ventral tegmental area

SAL–SAL n = 10

SAL–EtOH n = 10

EtOH–EtOH n = 10

P

15.6 ± 1.1 14.8 ± 0.4 15.4 ± 0.7 16.6 ± 0.5 16.1 ± 0.3 10.9 ± 0.4 12.8 ± 0.3 9.3 ± 0.5 12.0 ± 0.4 7.5 ± 1.4 1.0 ± 0.2

15.7 ± 0.6 15.0 ± 0.4 15.8 ± 0.5 16.9 ± 0.5 16.7 ± 0.4 11.6 ± 0.7 13.0 ± 1.0 7.6 ± 0.6 13.7 ± 0.4 9.9 ± 0.3 0.7 ± 0.1

15.5 ± 1.8 15.1 ± 0.4 15.6 ± 0.7 16.2 ± 0.8 15.6 ± 0.7 11.2 ± 0.7 13.0 ± 0.6 8.9 ± 0.7 13.4 ± 0.6 10.3 ± 0.3 1.0 ± 0.1

0.998 0.839 0.930 0.745 0.351 0.726 0.979 0.222 0.044 0.042 0.353

Values represent means ± SEM in pmol/g tissue. One-way ANOVA followed by Tukey-HSD or Dunnett-T3 test. Fig. 1. Locomotion frequency of mice which were treated with 1.8 g/kg ethanol (EtOH) or saline (SAL) for 21 consecutive days and received a challenge injection of 1.8 g/kg ethanol (-EtOH) or saline (-SAL) 24 h later. ⁎p b 0.001 compared to the SAL–SAL group. #p b 0.001 compared to the SAL–EtOH group. One-way ANOVA followed by Duncan’s test.

autoradiographic binding assays, in which one-way ANOVA was conducted on each of the 11 regions and the risk of a false positive (type-I errors) was higher, a correction factor (Bonferroni test) was also conducted for statistical significant findings. 3. Results 3.1. Experiment 1: Behavioral sensitization induced by ethanol repeated administration in mice Fig. 1 shows the effects of a challenge injection of 1.8 g/kg ethanol or saline on locomotion frequencies of mice repeatedly treated with

1.8 g/kg ethanol or saline. One-way ANOVA detected significant differences among the three groups in this behavioral parameter [F (2,27) = 13.06, p b 0.001]. Duncan’s post hoc test revealed that the EtOH–EtOH group presented a significant increase in locomotion frequency when compared to the other groups. In addition, the SAL– EtOH group exhibited higher locomotion frequency than that observed for the SAL–SAL group. 3.2. Experiment 2: D1 and D2 binding analyses during the expression of ethanol-induced behavioral sensitization in mice Fig. 2 illustrates the typical appearance of [3H] SCH-23390 and [3H] Raclopride binding at rostrocaudal levels of mice’s brains. Table 1 shows [3H] SCH 23390 binding to D1 receptors in several brain regions after an ethanol or a saline challenge injection in ethanol- or saline-treated mice. One-way ANOVA detected significant differences among the three groups in [3H] SCH 23390 binding to D1 receptors in the olfactory tubercle [F(2,27) = 3.50, p b 0.05) and in the substantia nigra [F(2,27) = 3.65, p b 0.05]. However, according to the Tukey-HSD test for the olfactory tubercle data and the Dunnett-T3 test for the substantia nigra data, no significant differences among groups were observed in these brain regions. As shown in Table 2, one-way ANOVA detected significant differences among the groups in [3H] Raclopride binding to D2 receptors only in the olfactory tubercle [F(2,27) = 4.13, p b 0.05]. The Tukey-HSD test revealed that the ethanol-sensitized group (EtOH– EtOH) presented significant reduced D2 binding values in the olfactory tubercle when compared to all the other groups.

Table 2 [3H]Raclopride binding to D2 receptors after a saline or an ethanol challenge injection in saline- or ethanol-treated mice SAL–SAL n = 10 SAL–EtOH n = 10 EtOH–EtOH n = 10 P

Fig. 2. Distribution of [3H]SCH 23390 (D1) and [3H]Raclopride (D2) binding at comparable rostrocaudal levels in normal mice’s brains. Acb = accumbens; CPu DL = caudate-putamen dorsolateral; CPu VL = caudate-putamen ventrolateral; CPu P = caudate-putamen posterior; Tu = olfactory tubercle; SN = substantia nigra.

Caudate-putamen Anterior Posterior Dorsomedial Dorsolateral Ventrolateral Nucleus accumbens Core Shell Olfactory tubercle Substantia Nigra Ventral tegmental area

5.9 ± 0.2 6.4 ± 0.3 5.5 ± 0.2 7.8 ± 0.2 7.8 ± 0.3 4.1 ± 0.2 4.6 ± 0.2 3.5 ± 0.2 3.8 ± 0.2 1.9 ± 0.1 0.6 ± 0.1

5.7 ± 0.2 6.4 ± 0.2 5.5 ± 0.2 7.7 ± 0.3 7.9 ± 0.3 3.9 ± 0.2 4.0 ± 0.2 3.1 ± 0.3 3.7 ± 0.2 1.7 ± 0.1 0.7 ± 0.1

5.7 ± 0.4 6.2 ± 0.3 5.5 ± 0.2 7.4 ± 0.2 7.6 ± 0.2 3.7 ± 0.2 4.1 ± 0.2 2.9 ± 0.3 3.1 ± 0.2 1.7 ± 0.1 0.7 ± 0.1

Values represent means ± SEM in pmol/g tissue. One-way ANOVA followed by Tukey-HSD test. ⁎ p b 0.05 compared to the SAL–SAL and SAL–EtOH groups.

0.840 0.841 0.965 0.412 0.686 0.365 0.116 0.290 0.030⁎ 0.455 0.557

N.P. de Araujo et al. / Physiology & Behavior 96 (2009) 12–17

4. Discussion The most important finding of this study was that mice which received an ethanol challenge injection after repeated treatment with this drug showed lower levels of D2 binding in the olfactory tubercle. As far as we know, this is the first paper examining the pattern of D1 and D2 binding in different brain regions at the time point that ethanol-treated (i.e., previously “sensitized”) animals received an ethanol challenge injection. This methodological issue is very relevant since it allowed us to study D1 and D2 receptor alterations during the expression of ethanol-induced behavioral sensitization. This phenomenon was behaviorally characterized in our study by an increase in locomotor activity of ethanol-treated animals in response to a challenge injection of this drug when compared to ethanol-challenged mice previously treated with saline (Fig. 1). Using this experimental protocol we found that D2 binding levels in the olfactory tubercle are decreased during the expression of ethanol-induced behavioral sensitization. Concerning a methodological issue, one could argue that the behavioral response analyzed (i.e., an increase in locomotion of ethanoltreated and -challenged mice, observed 5 min after ethanol injection in a 5-min session) would be in fact a reflection of the differences in anxietyrelated behaviors of animals withdrawn from ethanol versus animals not withdrawn from ethanol. However, this possibility seems unlikely since in our previous report [28], using the same subjects and experimental protocol, we have demonstrated that ethanol- and saline-treated mice presented similar locomotion frequencies in response to a saline challenge injection. We should state here that a group consisting of ethanol-treated mice challenged with saline (EtOH–SAL) was not included in the present study due to ethical purposes, since we have already demonstrated that under these same experimental conditions previous treatment with ethanol did not modify spontaneous locomotion of mice [28]. Thus, it seems unlikely that under our experimental conditions ethanol-treated mice developed a conditioned locomotor response to injection or an enhanced stress response to injection as a consequence of ethanol withdrawal. The use of female mice without concurrent estrous cycle tracking in our study could also raise the question whether neurochemical changes over the course of the estrous cycle might have contributed to the results obtained. Within this context, the pharmacokinetics of and motivation to self-administer ethanol are known to vary over the course of the rodent estrous cycle [39,40]. Despite evidence in the literature on the participation of estrous cycle in ethanol-induced behaviors, we have not tracked it during the experiments because stress induced by estrous cycle tracking would insert a confounding variable on our data. Within this context, it has been extensively demonstrated that different types of stress can potentiate the behavioral sensitization phenomenon [41–43]. Within this respect, since female rodents tend to develop more robust sensitization than male rats [44,45], female animals are frequently used (without estrous cycle tracking) to study the behavioral sensitization phenomenon, particularly ethanol-induced behavioral sensitization [46–49]. An interesting possibility to explain the reliability of such studies using female rodents may be the fact that the ovarian cycles of female rodents become synchronized when they live together, as do the cycles of many other mammals [50]. Concerning a methodological issue, it should be noted that since we used a single concentration of radiolabeled ligand, it is not possible to interpret our binding results as a change in receptor number or affinity. This concern notwithstanding, autoradiographic studies generally use only one concentration of the ligand, chosen from pharmacologic characterization in previous studies using homogenates. This chosen concentration leads to occupation of a high percentage of receptors (generally three times the Kd value). Although evaluation of receptor function was not performed in the current

15

study, this specific procedure provides a reliable evaluation of receptor binding [24,37]. Our result showing that D2 binding in the olfactory tubercle diminished in ethanol-sensitized animals suggests that changes in dopamine receptors in this region in response to ethanol treatment may play an important role in behavioral sensitization to this drug. In the last years, a great deal of importance has been given to D1 and D2 dopaminergic receptors, relating them to mechanisms surrounding behavioral sensitization to drugs of abuse, especially psychostimulants. However, most, if not all, studies have focused on D1 and/or D2 receptor alterations in structures such as the nucleus accumbens and the caudate-putamen. For instance, several authors have demonstrated that the development of a D1 functional supersensitivity in the nucleus accumbens seems to be a molecular marker for psychostimulants-induced behavioral sensitization [51–54]. In addition, Henry et al. [55] demonstrated that the D1 functional supersensitivity in the nucleus accumbens is accompanied and potentiated by the development of a functional subsensitivity of D2 autoreceptors in the ventral tegmental area. Regarding ethanol and its effects on D1 and D2 receptors, data from literature are contradictory. Thus, although ethanol increases the firing of dopamine neurons in the ventral tegmental area [56–58] and elevates extracellular dopamine concentration in the nucleus accumbens [59], elevation, reduction or no alteration in D1 and D2 binding have been reported after chronic treatment with this drug in several strains of rats and mice [21,24,37, 60–66]. More specifically, Souza-Formigoni et al. [24] observed an increase in D2 binding to the anterior and ventrolateral caudate-putamen of ethanol-sensitized Swiss mice 24 h after an ethanol challenge injection, i.e., 24 h after the expression of behavioral sensitization to ethanol (or during withdrawal from chronic treatment with ethanol). No alteration in D1 binding was found in any of the brain regions analyzed (caudateputamen, nucleus accumbens, olfactory tubercle, substantia nigra and others) in Swiss mice by Quadros et al. [37] using this same protocol of experiments. Likewise, Bailey et al. [23] found no alterations in D1 or D2 binding in the striatum of TO mice withdrawn from chronic ethanol consumption for 6 or 21 days. Nevertheless, Vasconcelos et al. [25] found decreases in D1 and D2 binding levels in the striatum of Wistar rats at a 48-h withdrawal from treatment with a high dose of ethanol. In this same study, withdrawal from the treatment with a lower dose of ethanol diminished only striatum D2 binding levels. The contradictory results obtained by these studies may be due to different subjects or strains of rodents used or, more likely, to different periods of withdrawal applied, which therefore might have accounted for the development of distinct neuroadaptations in D1 and D2 receptors. In spite of the contradictory findings about the effects of withdrawal from ethanol treatment on D1 and D2 receptors, our data suggest that repeated treatment and subsequent challenge with this drug do not modify D1 binding and specifically decrease D2 binding in the olfactory tubercle. It should be noted that although in previous studies [24,37] we have demonstrated an increase in D2 binding in the caudate-putamen and no alterations in D1 binding in any brain region using the same chronic ethanol administration protocol, those changes seem to be more closely related to abstinence from ethanol. Conversely, the different results obtained in the present study (a decrease in D2 binding in the olfactory tubercle) seem to be more closely associated with the expression of ethanol-induced behavioral sensitization. The present result emphasizes the importance of the olfactory tubercle, a usually neglected structure, on addiction processes and the behavioral sensitization phenomenon at least related to ethanol repeated administration. In fact, although both the nucleus accumbens and the olfactory tubercle receive efferences from dopamine neurons of the ventral tegmental area [67], only the former is usually considered a critical structure involved in the reinforcing effects of

16

N.P. de Araujo et al. / Physiology & Behavior 96 (2009) 12–17

drugs of abuse [see reference [68] for review] and behavioral sensitization processes [55]. Notwithstanding, studies conducted by Ikemoto's group have demonstrated that both the nucleus accumbens and the olfactory tubercle may play important roles in the rewarding effects of some drugs and in addiction processes [69,70]. In those studies, it was verified that naïve rats quickly learned to selfadminister amphetamine or high doses of cocaine infused into the medial accumbens shell or the medial olfactory tubercle. Conversely, another paper from Ikemoto's group [71] has demonstrated that, for MDMA, only the medial accumbens shell appears to support its selfadministration in naïve rats. Future studies involving repeated and/or challenge local injections of ethanol into the olfactory tubercle may clarify the specific role of this brain region in the ethanol-induced behavioral sensitization phenomenon. Some data from the literature have also demonstrated the importance of the olfactory tubercle in the locomotion of rodents, which is closely related to the behavioral sensitization phenomenon and, therefore, to addiction. In this regard, microinjections of amphetamine, dopamine or other direct dopamine agonists into the olfactory tubercle can facilitate locomotion [72]. Likewise, injections of mixtures of the D1 and D2 agonists SKF 38393 and quinpirole, or cocaine, into the olfactory tubercle (particularly the medial portion) induced vigorous locomotion in rats [73] and Cools [74] has demonstrated that injections of dopamine or the dopamine agonist apomorphine into the olfactory tubercle, but not into the nucleus accumbens, consistently increased rats’ locomotor activity in a familiar environment. Those data seem to be contradictory to the decrease in D2 receptor binding herein observed in the olfactory tubercle of ethanol-“sensitized” mice (i.e. with increased locomotor activity). However, the possibility may be raised that such a decrease in D2 binding is related to D2 dopamine autoreceptors, which is an interesting working hypothesis. To the extent that the observed receptor change in the olfactory tubercle may be relevant to ethanol-induced behavioral sensitization, our data would suggest that changes in the nucleus accumbens would not be critically involved in this specific process. This would be in line with the accumulating evidence suggesting that perhaps alterations in the nucleus accumbens would not be necessary to the development of ethanol addiction. In this regard, while rats self-administer ethanol in the ventral tegmental area [75], studies of 6-OHDA lesions clearly demonstrate that denervation of the nucleus accumbens does not interfere with ethanol consumption [76]. Likewise, in rats, the elevation of dopamine levels in the nucleus accumbens induced by a selective inhibitor of dopamine re-uptake does not modify ethanol self-administration [77]. According to Weiss and Porrino [78], these results indicate that ethanol self-administration is not dependent on dopamine activation in the nucleus accumbens. In summary, our results demonstrated reduced levels of D2 binding in the olfactory tubercle of mice presenting behavioral sensitization to ethanol. It is not clear how important those changes are for locomotion or behavioral sensitization to ethanol, requiring further investigation. Indeed, an association between changes in dopamine D2 receptor expression and a change in behavioral response does not prove a cause-and-effect relationship. This concern notwithstanding, our data emphasize that more studies of ethanol addiction should focus in other brain regions rather than the nucleus accumbens. Acknowledgements This research was supported by fellowships from the Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP), from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), from the Fundação Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), from the Fundo de Apoio ao Docente e Aluno (FADA), and from the Associação Fundo de Pesquisa em Psicobiologia (AFIP). The authors would like to thank Ms. Teotila R. R. Amaral, Mr. Cleomar S. Ferreira and Mr. Antônio R. Santos for capable technical assistance.

References [1] De Vries TJ, Schoffelmeer AN, Binnekade R, Mulder AH, Vanderschuren LJ. Druginduced reinstatement of heroin- and cocaine-seeking behaviour following longterm extinction is associated with expression of behavioural sensitization. Eur J Neurosci 1988;10(11):3565–71. [2] Hotsenpiller G, Horak BT, Wolf ME. Dissociation of conditioned locomotion and Fos induction in response to stimuli formerly paired with cocaine. Behav Neurosci 2002;116(4):634–45. [3] Piazza PV, Deminiere JM, Le Moal M, Simon H. Stress- and pharmacologicallyinduced behavioral sensitization increases vulnerability to acquisition of amphetamine self-administration. Brain Res 1990;514(1):22–6. [4] Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 1986;396:157–98. [5] Alvarez J do N, Fukushiro DF, Tatsu JA, de Carvalho EP, Gandolfi AC, Tsuchiya JB, et al. Amphetamine-induced rapid-onset sensitization: role of novelty, conditioning and behavioral parameters. Pharmacol Biochem Behav 2006;83(4):500–7. [6] Chinen CC, Faria RR, Frussa-Filho R. Characterization of the rapid-onset type of behavioral sensitization to amphetamine in mice: role of drug-environment conditioning. Neuropsychopharmacology 2006;31(1):151–9. [7] Wise RA, Gingras MA, Amit Z. Influence of novel and habituated testing conditions on cocaine sensitization. Eur J Pharmacol 1996;307:15–9. [8] Nestler EJ, Self DW. In: Yudofsky SC, Hales RE, editors. Text book of neuropsychiatry. third ed. Washington DC: American Psychiatric Press; 1997. p. 773–98. [9] Masur J, Boerngen R. The excitatory component of ethanol in mice: a chronic study. Pharmacol Biochem Behav 1980;13:777–80. [10] Masur J, Souza MLO, Zwicker AP. The excitatory effect of ethanol: absence in rats, no tolerance and increased sensitivity in mice. Pharmacol Biochem Behav 1986;24:1225–8. [11] Robinson TE, Berridge KC. The neural basis of drug craving: an incentivesensitization theory of addiction. Brain Res Rev 1993;18:247–91. [12] Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev 1987;94:469–92. [13] Henry DJ, White FJ. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 1991;258:882–90. [14] Le Moal M. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology: the fourth generation of progress. New York: Raven Press; 1995. [15] Segal DS, Kelly P, Roberts DCS. Catecholamines: basic and clinical frontiers, vol. 2. New York: Pergamon Press; 1979. p. 1672–4. [16] Wolf ME, White FJ, Hu XT. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 1994;14(Part 2):1735–45. [17] Noble EP. Alcoholism and the dopaminergic system—a review. Addict Biol 1996;1:333–348. [18] Soyka M, De Vry J. Flupenthixol as a potential pharmacotreatment of alcohol and cocaine abuse/dependence. Eur Neuropsychopharmacol 2000;10(5):325–32. [19] Volkow ND, Wang GJ, Fowler JS, Logan J, Hitzemann R, Ding YS, et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 1996;20:1594–8. [20] Bari AA, Pierce RC. D1-like and D2 dopamine receptor antagonists administered into the shell subregion of the rat nucleus accumbens decrease cocaine, but not food, reinforcement. Neuroscience 2005;135(3):959–68. [21] Hruska RE. Effects of ethanol administration on striatal D1 and D2 dopamine receptors. J Neurochem 1988;50:1929–33. [22] Pecins-Thompson M, Peris J. Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration. Psychopharmacology 1993;110:443–50. [23] Bailey CP, O'Callaghan MJ, Croft AP, Manley SJ, Little HJ. Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption. Neuropharmacology 2001;41(8):989–99. [24] Souza-Formigoni MLO, De Lucca EM, Hipólide DC, Enns SC, Oliveira MGM, Nobrega JN. Sensitization to ethanol's stimulant effect is associated with region-specific increases in brain D2 receptor binding. Psychopharmacology 1999;146:262–7. [25] Vasconcelos SM, Macedo DS, Lima LO, Sousa FC, Fonteles MM, Viana GS. Effect of one-week ethanol treatment on monoamine levels and dopaminergic receptors in rat striatum. Braz J Med Biol Res 2003;36(4):503–9. [26] Bellot RG, Camarini R, Vital MABF, Palermo-Neto J, Leyton V, Frussa-Filho R. Monosialoganglioside attenuates the excitatory and behavioural sensitization effects of ethanol. Eur J Pharmacol 1996;313:175–9. [27] Araujo NP, Camarini R, Souza-Formigoni MLO, Carvalho RC, Abilio VC, Silva RH, et al. The importance of housing conditions on behavioral sensitization and tolerance to ethanol. Pharmacol Biochem Behav 2005;82:40–5. [28] Araujo NP, Fukushiro DF, Cunha JL, Levin R, Chinen CC, Carvalho RC, et al. Druginduced home cage conspecifics’ behavior can potentiate behavioral sensitization in mice. Pharmacol Biochem Behav 2006;84(1):142–7. [29] Araujo NP, Andersen ML, Abílio VC, Gomes DC, Carvalho RC, Silva RH, et al. Sleep deprivation abolishes the locomotor stimulant effect of ethanol in mice. Brain Res Bull 2006;69(3):332–7. [30] Camarini R, Frussa-Filho R, Monteiro MG, Calil HM. MK-801 blocks the development of behavioral sensitization to ethanol. Alcohol Clin Exp Res 2000;24(3):285–90. [31] Costa FG, Frussa-Filho R, Felicio LF. The neurotensin receptor antagonist, SR48692, attenuates the expression of amphetamine-induced behavioural sensitization in mice. Eur J Pharmacol 2001;428(1):97–103. [32] Frussa-Filho R, Gonçalves MT, Andersen ML, Araujo NP, Chinen CC, Tufik S. Paradoxical sleep deprivation potentiates amphetamine-induced behavioural

N.P. de Araujo et al. / Physiology & Behavior 96 (2009) 12–17

[33]

[34]

[35]

[36]

[37]

[38] [39] [40] [41]

[42]

[43]

[44] [45]

[46] [47]

[48]

[49] [50] [51]

[52] [53]

[54] [55]

sensitization by increasing its conditioned component. Brain Res 2004;1003(1–2): 188–93. Frussa-Filho R, Palermo-Neto J. Effects of single and long-term administration of sulpiride on open-field and stereotyped behavior of rats. Braz J Med Biol Res 1990;23(5):463–72. Frussa-Filho R, Palermo-Neto J. Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats. Physiol Behav 1991;50(4):825–30. Frussa-Filho R, Rocha JB, Conceição IM, Mello CF, Pereira ME. Effects of dopaminergic agents on visceral pain measured by the mouse writhing test. Arch Int Pharmacodyn Ther 1996;331(1):74–93. Fukushiro DF, Alvarez Jdo N, Tatsu JA, de Castro JP, Chinen CC, Frussa-Filho R. Haloperidol (but not ziprasidone) withdrawal enhances cocaine-induced locomotor activation and conditioned place preference in mice. Prog Neuropsychopharmacol Biol Psychiatry 2007;31(4):867–72. Quadros IMH, Nobrega JN, Hipólide DC, De Lucca EM, Souza-Formigoni MLO. Differential propensity to ethanol sensitization is not associated with altered binding to D1 receptors or dopamine transporters in mouse brain. Addict Biol 2002;7:291–9. Franklin KBJ, Paxinos G. The mouse brain in stereotaxic coordinates. New York: Academic Press; 1997. Lynch WJ, Roth ME, Carroll ME. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 2002;164:121–37. Robinson DL, Brunner LJ, Gonzales RA. Effect of gender and estrous cycle on the pharmacokinetics of ethanol in the rat brain. Alcohol Clin Exp Res 2002;26:165–72. Miczek KA, Nikulina E, Kream RM, Carter G, Espejo EF. Behavioral sensitization to cocaine after a brief social defeat stress: c-fos expression in the PAG. Psychopharmacology (Berl) 1999;141(3):225–34. Nikulina EM, Covington 3rd HE, Ganschow L, Hammer Jr RP, Miczek KA. Long-term behavioral and neuronal cross-sensitization to amphetamine induced by repeated brief social defeat stress: Fos in the ventral tegmental area and amygdala. Neuroscience 2004;123(4):857–65. Robinson TE, Angus AL, Becker JB. Sensitization to stress: the enduring effects of prior stress on amphetamine-induced rotational behavior. Life Sci 1985;37 (11):1039–42. Forgie ML, Stewart J. Effect of prepubertal ovariectomy on amphetamine-induced locomotor activity in adult female rats. Horm Behav 1994;28:241–60. Robinson TE. Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology 1984;84:466–75. Lessov CN, Phillips TJ. Duration of sensitization to the locomotor stimulant effects of ethanol in mice. Psychopharmacology 1998;135:374–82. Phillips TJ, Huson M, Gwiazdon C, Burkhart-Kasch S, Shen EH. Effects of acute and repeated ethanol exposures on the locomotor activity of BXD recombinant inbred mice. Alcohol Clin Exp Res 1995;19:269–78. Phillips TJ, Lessov CN, Harland RD, Mitchell SR. Evaluation of potential genetic associations between ethanol tolerance and sensitization in BXD/Ty recombinant inbred mice. J Pharmacol Exp Ther 1996;277:613–23. Roberts AJ, Lessov CN, Phillips TJ. Critical role for glucocorticoid receptors in stressand ethanol-induced locomotor sensitization. J Pharmacol Exp Ther 1995;275:790–7. Schank JC, McClintock MK. A coupled-oscillator model of ovarian-cycle synchrony among female rats. J Theor Biol 1992;157:317–62. Li Y, Hu XT, Berney TG, Vartanian AJ, Stine CD, Wolf ME, et al. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 1999;34:169–80. Pierce RC, Kalivas PW. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 1997;25:192–216. Vanderschuren LJMJ, Kalivas PW. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 2000;151:99–120. Wolf ME. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Progr Neurobiol 1998;54:679–720. Henry DJ, Hu XT, White FJ. Adaptations in the mesoaccumbens dopamine system resulting from repeated administration of dopamine D1 and D2 receptor-selective agonists: relevance to cocaine sensitization. Psychopharmacology 1998;140:233–42.

17

[56] Brodie MS, Shefner SA, Dunwiddie TV. Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro. Brain Res 1990;508:65–9. [57] Brodie MS, Pesold C, Appel SB. Ethanol directly excites dopaminergic ventral tegmental area reward neurons. Alcohol Clin Exp Res 1999;23:1848–52. [58] Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu G. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 1985;348:201–3. [59] Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci 1988;85:5274–8. [60] Fuchs V, Coper H, Rommelspacher H. The effects of ethanol and haloperidol on dopamine receptors (D2) density. Neuropharmacology 1987;26:1231–3. [61] Hamdi A, Prasad C. Bidirectional changes in striatal D1-dopamine receptor density during chronic ethanol intake. Life Sci 1993;52:251–7. [62] Hietala J, Salonen I, Lappalainen J, Syvalahti E. Ethanol administration does not alter dopamine D1 and D2 receptor characteristics in rat brain. Neurosci Lett 1990;108:289–94. [63] Lograno DE, Matteo F, Trabucchi M, Govoni S. Effects of chronic ethanol intake at a low dose on the rat brain dopaminergic system. Alcohol 1993;10:45–9. [64] Rabin RA, Wolfe BB, Dibner MD, Zahniser NR, Melchior C, Molinoff PB. Effects of ethanol administration and withdrawal on neurotransmitter receptor systems in C57mice. J Pharmacol Exp Ther 1983;213:491–6. [65] Reggiani A, Barbaccia ML, Spano PF, Trabucci M. Dopamine metabolism and receptor function after acute and chronic ethanol. J Neurochem 1980;35:34–7. [66] Wolffgramm J, Rommelspacher H, Buck E. Ethanol reduces tolerance, sensitization, and up-regulation of D2-receptors after subchronic haloperidol. Pharmacol Biochem Behav 1990;36:907–14. [67] Drukarch ML, Stoof JC. D-2 dopamine autoreceptor selective drugs: do they really exist? Life Sci 1990;47:361–76. [68] Kalivas PW. Neurocircuitry of addiction. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: the fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 1357–66. [69] Ikemoto S. Involvement of the olfactory tubercle in cocaine reward: intracranial self-administration studies. J Neurosci 2003;23(28):9305–11. [70] Ikemoto S, Qin M, Liu ZH. The functional divide for primary reinforcement of Damphetamine lies between the medial and lateral ventral striatum: is the division of the accumbens core, shell and olfactory tubercle valid? J Neurosci 2005;25(20):5061–5. [71] Shin R, Qin M, Liu ZH, Ikemoto S. Intracranial self-administration of MDMA into the ventral striatum of the rat: differential roles of the nucleus accumbens shell, core, and olfactory tubercle. Psychopharmacology 2008;198:261–70. [72] Pijnenburg AJ, Honig WM, Van der Heyden JA, Van Rossum JM. Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 1976;35(1):45–58. [73] Ikemoto S. Ventral striatal anatomy of locomotor activity induced by cocaine, Damphetamine, dopamine and D1/D2 agonists. Neuroscience 2002;113(4):939–55. [74] Cools AR. Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens. Psychopharmacology (Berl) 1986;88 (4):451–9. [75] Rodd-Henricks ZA, Mckinzie DL, Crile RS, Murphy JM, Mcbride WJ. Regional heterogeneity for the intracranial self-administration of ethanol within the ventral tegmental area of female Wistar rats. Psychopharmacology 2000;149:217–24. [76] Ikemoto S, Mcbride WJ, Murphy JM, Lumeng L, Li TK. 6-OHDA-lesions of the nucleus accumbens disrupt the acquisition but not the maintenance of ethanol consumption in the alcohol-preferring P line of rats. Alcohol Clin Exp Res 1997;21:1042–1046. [77] Engleman EA, Mcbride WJ, Wilber AA, Shaikh SR, Eha RD, Lumeng L, et al. Reverse microdialysis of a dopamine uptake inhibitor in the nucleus accumbens of alcoholpreferring rats: effects on dialysate dopamine levels and ethanol intake. Alcohol Clin Exp Res 2000;24:795–801. [78] Weiss F, Porrino LJ. Behavioral neurobiology of alcohol addiction: recent advances and challenges. J Neurosci 2002;22(9):3332–7.